Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Function drives 1-year decision regret in radical prostatectomy: a multicentre prospective study.

BJU international·2026
Same author

Procedure efficiency and diagnostic outcomes during the learning curve of transperineal MRI-guided prostate biopsy.

BJUI compass·2026
Same author

Trends in surgical management of hypospadias in Germany: A nationwide analysis on legislative and guideline changes.

Journal of pediatric urology·2026
Same author

Ablative radiotherapy in castration-resistant prostate cancer.

BJU international·2026
Same author

Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson's disease-relevant LRRK2-G2019S mutation.

iScience·2026
Same author

Knowledge Gaps and Barriers to Care in Men with Postprostatectomy Incontinence: Evidence from the German ProKontinenz Trial.

European urology open science·2026

Related Experiment Video

Updated: May 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients.

Marcus Sondermann1, Hannah Glaser2, Anke Rentsch3

  • 1Department of Urology University Hospital Carl Gustav Carus, TU Dresden Dresden Germany.

BJUI Compass
|August 20, 2025
PubMed
Summary

Machine learning models show potential for automating prostate cancer treatment recommendations from multidisciplinary tumour boards (MTBs). While accurate for local therapies, further optimization is needed for broader clinical use.

Keywords:
artificial intelligencedecision supportmachine learningprostate cancertumour board

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

221

Related Experiment Videos

Last Updated: May 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

221

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning

Background:

  • Multidisciplinary tumour boards (MTBs) are crucial for prostate cancer management but are time-intensive.
  • Automating MTB recommendations can improve accessibility and efficiency.

Purpose of the Study:

  • To evaluate machine learning (ML) algorithms for automating diagnostic and therapeutic recommendations in prostate cancer patient management.
  • To assess the performance of Decision Tree, Random Forest, and K-Nearest Neighbours (KNN) algorithms in predicting MTB decisions.

Main Methods:

  • A retrospective dataset of 1929 MTB recommendations (2020-2024) was utilized.
  • Three ML algorithms were trained to predict recommendations for PSMA-PET, conventional imaging, active surveillance, and local therapy.
  • Model performance was evaluated using accuracy, precision, recall, and F1-score.

Main Results:

  • The Random Forest model achieved the highest overall accuracy (66.3%).
  • High accuracy was observed for local therapy predictions (F1-score: 0.99).
  • Performance was lower for less frequent recommendations (PSMA-PET, active surveillance) due to class imbalance and guideline changes.

Conclusions:

  • ML holds promise for replicating MTB decision-making patterns in prostate cancer.
  • Current models require further optimization for clinical application, serving as a proof-of-concept.
  • Future research should focus on multi-institutional data, prospective validation, and adaptation to evolving guidelines.